Evidence map›Paper›PMID 38630389›Full record

ReviewWorld journal of microbiology & biotechnology2024

Research and application progress of microbial β-mannanases: a mini-review.

Ping Wang, Xiaohui Pei, Weiqiang Zhou, Yue Zhao, Pengfei Gu, Yumei Li, Juan Gao

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ping Wang *School of Biological Science and Technology, University of Jinan, Jinan, 250022, PR China.
Xiaohui Pei *Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Shandong First Medical University, Taian, 271000, PR China.
Weiqiang ZhouWeili Biotechnology (Shandong) Co., Ltd, Taian, 271400, PR China.
Yue ZhaoSchool of Biological Science and Technology, University of Jinan, Jinan, 250022, PR China.
Pengfei GuSchool of Biological Science and Technology, University of Jinan, Jinan, 250022, PR China.
Yumei LiSchool of Biological Science and Technology, University of Jinan, Jinan, 250022, PR China. mls_liym@ujn.edu.cn.
Juan GaoSchool of Biological Science and Technology, University of Jinan, Jinan, 250022, PR China. bio_gaoj@ujn.edu.cn.
University of Jinan · CNBeike Biotechnology (China) · CNShandong First Medical University · CN

Funding

Key R&D Program of Shandong Province 2022SFGC0102the Innovation Capability Improvement Project of technology-based medium and small enterprises in Shandong Province 2021TSGC1247
6 · The paper itself

Abstract

Mannan is a predominant constituent of cork hemicellulose and is widely distributed in various plant tissues. β-Mannanase is the principal mannan-degrading enzyme, which breaks down the β-1,4-linked mannosidic bonds in mannans in an endo-acting manner. Microorganisms are a valuable source of β-mannanase, which exhibits catalytic activity in a wide range of pH and temperature, making it highly versatile and applicable in pharmaceuticals, feed, paper pulping, biorefinery, and other industries. Here, the origin, classification, enzymatic properties, molecular modification, immobilization, and practical applications of microbial β-mannanases are reviewed, the future research directions for microbial β-mannanases are also outlined.

Indexed as

beta-MannosidaseMannansTemperaturebeta-MannosidaseMannansApplicationCatalytic mechanismEnzymatic propertyMicrobial β-mannanaseMolecular modification

Identifiers

PMID38630389
OpenAlexW4394873334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.